Fundraising FoxSnickpick Investment
Venture capitalSeoul · Seed–Series A · 8 people tracked
Find your way into Snickpick Investment
Sign up to see every warm intro you have to Snickpick Investment
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Snickpick Investment team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm concentrates on small and medium-sized ventures leading the bio and healthcare sector. Rather than pursuing short-term returns, it positions itself as an investment institution that helps build a foundation for long-term growth alongside its portfolio companies. It brings deep, diverse expertise from professionals experienced in the biohealthcare industry, and emphasizes a healthy corporate culture grounded in transparency and ethical management.
Source: firm website, verified Oct 26, 2026.
Team · 8 people
from the firm's websiteServes as the representative director (CEO) of the firm.
Partner who previously served as CTO/development head at Hugel and held research professor positions at Seoul National University's genetic engineering institute and industry-academia cooperation foundation.
Management staff member trained in a venture capital administration new-talent program; previously with Daejeon Nambu Saemaul Geumgo.
Investment reviewer trained in a venture capital new-talent program; previously with IMM Investment's Growth Equity division and Company K Partners' VC division.
Advisor currently chairman of Cellac Bio; formerly founder and CEO of Hugel, a research professor at KAIST, and affiliated with Memorial Sloan Kettering Cancer Center.
Management staff member trained in a venture capital administration new-talent program.
Auditor who is a partner attorney at Seum law firm and an adjunct professor at KAIST; previously a prosecutor in the financial crimes unit and an attorney at the Financial Supervisory Service.
Director with prior VC experience at Yuanta Investment and SL Investment, and operating roles at SK Biopharm, Daewoong Pharmaceutical, and Dong-A ST.
What they invest in
from 1 of 9 portfolio companiesBiotech ×1Digital Health ×1Medical Devices ×1
HQs:South Korea×1
Investments · 9 tracked
founders shown can be your intro pathGeneCker develops CRISPR/Cas9-based liquid biopsy diagnostics for early cancer detection, analyzing low-frequency circulating tumor DNA (ctDNA) mutations in blood.
BiotechDigital HealthMedical Devices
Seonghyeok Ye(Co-Founder & Co-CEO)Junseok W. Hur(Co-Founder & Co-CEO)Kyung-Hak Choi(VP)In-Seon Lee(Lead, Product Development Team & Molecular Diagnostics Laboratory)
Co-investorsSBI Investment Korea Co. Ltd.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
갤럭스넥셀메디맵바이오스카이랩스아바타테라퓨틱스윌로그진씨커피알지에스앤텍
Frequently asked questions
- How many investments has Snickpick Investment made?
- Snickpick Investment has 9 tracked investments.
- What stage does Snickpick Investment invest at?
- Snickpick Investment invests at the Seed, Series A stages.
- What sectors does Snickpick Investment focus on?
- Snickpick Investment focuses on Biotech, Digital Health, Healthtech.
- Where is Snickpick Investment located?
- Snickpick Investment is headquartered in Seoul, KR.
Images
Similar investors
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
Echo Health Ventures is a strategic investing platform backed by an alliance of health plans, focused on scaling healthcare innovation to improve affordability, access and outcomes.
Frist Cressey Ventures (FCV) is a venture capital firm focused on transforming healthcare and improving lives, offering portfolio companies strategic support alongside capital.
Treo Ventures is an investment firm focused on medical device and digital health innovation aimed at significantly impacting human life, backing companies in the US and Europe.
Kaiser Permanente Ventures is the corporate venture investing arm focused on healthcare companies addressing meaningful needs for patients, providers, and healthcare delivery systems.